Your browser version may not work well with NCBI's Web applications. More information here...
1: Int J Clin Pract. 2004 Jul;58(7):669-74.Click here to read Links
Comment in:
Int J Clin Pract. 2004 Jul;58(7):650-2.

An investigation into the 'carry over' effect of neurostimulation in the treatment of angina pectoris.

Department of Cardiology, Taunton & Somerset Hospital, Taunton, Somerset, UK. drstevemurray@lycos.co.uk

Neurostimulation, by way of transcutaneous electrical nerve stimulation (TENS) and spinal cord stimulation, improves signs and symptoms of myocardial ischaemia, with evidence (from non-randomised studies) that this effect extends beyond the period of stimulation itself ('carry-over' effect). In this randomised controlled trial, 10 patients underwent baseline treadmill-exercise-testing (TET), followed by two further tests at fortnightly intervals. TENS was compared to placebo in a randomised fashion. TENS produced a significant increase in total exercise time (399.3 vs. 364.5 s, p < 0.05) and time to maximum ST depression (374 vs. 324 s, p = 0.01) without a significant difference in the maximum degree of ST depression (2.0 vs. 2.1 mm, p = NS). Rate-pressure product at peak exercise was not significantly different (197 vs. 193, p = NS). TENS produced a nonsignificant change in time to onset of angina (352 vs. 325 s, p = 0.07). Pre-treatment with TENS produces a significant improvement in exercise tolerance and measures of ischaemia but not significant improvement in symptoms.

PMID: 15311723 [PubMed - indexed for MEDLINE]